Rhesus monkey immature monocyte-derived dendritic cells generate alloantigen-specific regulatory T cells from circulating CD4 +CD127-/lo T cells

Transplantation

Volumn 88, Issue 9, 2009, Pages 1057-1064

  Zahorchak, Alan F ^a   Raimondi, Giorgio ^a   Thomson, Angus W ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Dendritic cells; Interleukin 10; Regulatory T cells.; Rhesus monkey; Vitamin D3

Indexed keywords

ALLOANTIGEN; COLECALCIFEROL; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 10; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR; TRANSCRIPTION FACTOR FOXP3;

ANIMAL CELL; ARTICLE; CD4+ CD127+ T LYMPHOCYTE; CD4+ CD127-/LO T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CLONAL ANERGY; CONTROLLED STUDY; CRYOPRESERVATION; DENDRITIC CELL; FLOW CYTOMETRY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MIXED LEUKOCYTE CULTURE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; RHESUS MONKEY; STATISTICAL ANALYSIS;

ANIMALS; ANTIBODIES, MONOCLONAL; CD4-POSITIVE T-LYMPHOCYTES; COCULTURE TECHNIQUES; CRYOPRESERVATION; DENDRITIC CELLS; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-7 RECEPTOR ALPHA SUBUNIT; ISOANTIGENS; MACACA MULATTA; MALE; MONOCYTES; SPECIES SPECIFICITY; T-LYMPHOCYTES, REGULATORY;

EID: 72949097831     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181ba6b1f     Document Type: Article

References (45)

1. Kirk AD. Crossing the bridge: Large animal models in translational transplantation research. Immunol Rev 2003; 196: 176.
2. Kean LS, Gangappa S, Pearson TC, et al. Transplant tolerance in non-human primates: Progress, current challenges and unmet needs. Am J Transplant 2006; 6 (5 Pt 1): 884.
3. Hart BA, Amor S, Jonker M. Evaluating the validity of animal models for research into therapies for immune-based disorders. Drug Discov Today 2004; 9: 517.
4. Bluestone JA. Regulatory T-cell therapy: Is it ready for the clinic? Nat Rev Immunol 2005; 5: 343.
5. Bluestone JA, Thomson AW, Shevach EM, et al. What does the future hold for cell-based tolerogenic therapy? Nat Rev Immunol 2007; 7: 650.
6. Wood KJ, Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003; 3: 199.
7. Golshayan D, Jiang S, Tsang J, et al. In vitro-expanded donor alloantigen-specific CD4+CD25 + regulatory T cells promote experimental transplantation tolerance. Blood 2007; 109: 827.
8. Xia G, He J, Leventhal JR. Ex vivo-expanded natural CD4+CD25 + regulatory T cells synergize with host T-cell depletion to promote long-term survival of allografts. Am J Transplant 2008; 8: 298.
9. Joffre O, Gorsse N, Romagnoli P, et al. Induction of antigen-specific tolerance to bone marrow allografts with CD4+CD25+ T lymphocytes. Blood 2004; 103: 4216.
10. Trenado A, Charlotte F, Fisson S, et al. Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia. J Clin Invest 2003; 112: 1688.
11. Sakaguchi S, Yamaguchi T, Nomura T, et al. Regulatory T cells and immune tolerance. Cell 2008; 133: 775.
12. Sakaguchi S. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004; 22: 531.
13. Vignali DA, Collison LW, Workman CJ. How regulatory T cells work. Nat Rev Immunol 2008; 8: 523.
14. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003; 4: 330.
15. Gavin MA, Torgerson TR, Houston E, et al. Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc Natl AcadSci USA2006; 103:6659.
16. Wang J, Ioan-Facsinay A, van der Voort EI, et al. Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells. Eur J Im-munol2007; 37: 129.
17. Dai Z, Li Q, Wang Y, et al. CD4+CD25+ regulatory T cells suppress allograft rejection mediated by memory CD8+ T cells via a CD30-dependent mechanism. J Clin Invest 2004; 113: 310.
18. KingsleyC, Karim M, Bushell A, et al. CD25 + CD4+ regulatoryTcells prevent graft rejection: CTLA-4-and IL-10-dependent immunoregu-lation of alloresponses. J Immunol 2002; 168: 1080.
19. Hoffmann P, Eder R, Kunz-Schughart LA, et al. Large-scale in vitro expansion of polyclonal human CD4(+)CD25 high regulatory T cells. Blood2004; 104: 895.
20. Godfrey WR, Ge YG, Spoden DJ, et al. In vitro-expanded human CD4( + )CD25(+) T-regulatory cells can markedly inhibit allogeneic dendritic cell-stimulated MLR cultures. Blood 2004; 104: 453.
21. Peters JH, Preijers FW, Woestenenk R, et al. Clinical grade Treg: GMP isolation, improvement of purity by CD127 Depletion, Treg expansion, and Treg cryopreservation. PLoS One 2008; 3: e3161.
22. Jiang S, CamaraN, Lombardi G, et al. Induction of allopeptide-specific human CD4+CD25+ regulatory T cells ex vivo. Blood 2003; 102:2180.
23. Yamazaki S, Inaba K, Tarbell KV, et al. Dendritic cells expand antigen-specific Foxp3+ CD25+ CD4+ regulatory T cells including suppressors of alloreactivity. ImmunolRev 2006; 212: 314.
24. + T regulatory cells and promote organ transplant tolerance. J Immunol 2007; 178: 7018.
25. Gansuvd B, Asiedu CK, Goodwin J, et al. Expansion of CD4+CD25 + suppressive regulatory T cells from rhesus macaque peripheral blood by FN18/antihuman CD28-coated Dynal beads. Hum Immunol 2007; 68: 478.
26. Hartigan-O'Connor DJ, Abel K, McCune JM. Suppression of SIV-specific CD4 + T cells by infant but not adult macaque regulatory T cells: Implications for SIV disease progression. J Exp Med 2007; 204:2679.
27. Haanstra KG, van der Maas MJ, Hart BA, et al. Characterization of naturally occurring CD4+CD25+ regulatory T cells in rhesus monkeys. Transplantation 2008; 85: 1185.
28. Moreau A, Chiffoleau E, Beriou G, et al. Superiority of bone marrow-derived dendritic cells over monocyte-derived ones for the expansion of regulatory T cells in the macaque. Transplantation 2008; 85: 1351.
29. Porter CM, Horvath-Arcidiacono JA, Singh AK, et al. Characterization and expansion of baboon CD4+CD25+ Treg cells for potential use in a non-human primate xenotransplantation model. Xenotransplantation 2007; 14: 298.
30. Anderson A, Martens CL, Hendrix R, et al. Expanded nonhuman primate Tregs exhibit a unique gene expression signature and potently downregulate alloimmune responses. Am J Transplant 2008; 8: 2252.
31. Liu W, Putnam AL, Xu-Yu Z, et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 2006; 203: 1701.
32. Seddiki N, Santner-Nanan B, Martinson J, et al. Expression of interleu-kin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 2006; 203: 1693.
33. Zahorchak AF, Kean LS, Tokita D, et al. Infusion of stably immature monocyte-derived dendritic cells plus CTLA4Ig modulates alloimmune reactivity in rhesus macaques. Transplantation 2007; 84: 196.
34. Penna G, Adorini L. 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 2000; 164: 2405.
35. Steinbrink K, Wolfl M, Jonuleit H, et al. Induction of tolerance by IL-10-treated dendritic cells. J Immunol 1997; 159: 4772.
36. Hackstein H, Thomson AW. Dendritic cells: Emerging pharmacological targets of immunosuppressive drugs. Nat Rev Immunol 2004; 4: 24.
37. Tang Q, Bluestone JA. The Foxp3+ regulatory T cell: A jack of all trades, master of regulation. Nat Immunol 2008; 9: 239.
38. + T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med 2000; 192: 1213.
39. Levings MK, Gregori S, Tresoldi E, et al. Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4 + Tr cells. Blood 2005; 105: 1162.
40. Adorini L, Penna G, Giarratana N, et al. Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting allograft rejection and autoimmune diseases. JCellBiochem 2003; 88:227.
41. Mirenda V, Berton I, Read J, et al. Modified dendritic cells coexpressing self and allogeneic major histocompatibility complex molecules: An efficient way to induce indirect pathway regulation. J Am Soc Nephrol 2004; 15: 987.
42. Hackstein H, Taner T, Zahorchak AF, et al. Rapamycin inhibits IL-4-Induced dendritic cell maturation in vitro and dendritic cell mobilization and function in vivo. Blood 2003; 101: 4457.
43. Roncarolo MG, Battaglia M. Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. Nat Rev Immunol 2007; 7: 585.
44. Raimondi G, Sumpter TL, Matta B, et al. Induction of heart transplant tolerance by post-transplant administration of allo-Ag apecific Treg and rapamycin. Am J Transplant 2008; 8: 249 (abstract no. 266).
45. Anderson AE, Sayers BL, Haniffa MA, et al. Differential regulation of naive and memory CD4+ T cells by alternatively activated dendritic cells. J Leukoc Biol 2008; 84: 124.